India needs to change its Covid vaccination strategy now. Here’s how it can do it

More than two months into India’s vaccination drive towards Covid-19, the initiative is being met with what’s seen as ‘vaccine restlessness’, a time period that discovered point out within the Government of India Communication Strategy doc detailing the eagerness of individuals to get a shot towards Covid-19.

The improve in ‘vaccine restlessness’ has been instantly proportional to the discount in ‘vaccine hesitancy’ and worry of extra restrictions as atleast one state within the nation sees a second wave of the an infection.

The refrain for permitting everybody to get a dose of the vaccine is barely getting louder. Restlessness will not be with out purpose.


Maharasthra’s Covid-19 figures have been worrying. Contributing to 60 per cent of the Covid caseload within the nation with greater than 25,000 circumstances for per week now, the state is seeing localised lockdowns and the worry is that very quickly we might arrive at a state of affairs that sees issues slip out of our fingers.

Increasing infections in Mumbai’s impoverished tenements is very concerning as these areas had very high seroprevalence several months back. We need to understand if there are re-infections and if these are due to declining antibodies or due to an immune escape variant. There may be some combination of a SARS-CoV-2 variant, declining protective immunity and lower compliance with safety measures. In the days ahead, we are likely to see a similar rise in cases across the country,” says Dr Swapneil Parikh, creator of ‘The Coronavirus’.

What then is required?


“A new vaccine coverage strategy is needed because the current strategy will take long to reach herd immunity in the whole country. Without herd immunity, Covid-19 transmission will not stop,” says Dileep Mavalankar, Director, Institute of Public Health.

“With a focused city coverage strategy, local herd immunity will be reached much faster in selected high incidence areas and disease will go down rapidly,” he provides.

For this, bringing in additional individuals into the ambit of the vaccination drive by stress-free the age and co-morbidities standards needs to be the best way ahead.

“We need to prioritize areas with rising cases for urgent vaccination and focus on the elderly, those with high-risk medical conditions, immunocompromised patients and essential workers,” says Dr Parikh.


“We do not have enough doses of the vaccine to even cover the priority group by July,” Dr Randeep Guleria, Director of Delhi’s AIIMS, informed India Today TV when requested a query on why India will not be opening up vaccinations.

Even the primary part of the vaccination drive involving 30 crore Indians would require 60 crore doses.

Up till now, two vaccines below restricted use authorisation are getting used within the nation.

There are others within the line. Sputnik V, developed by Russia’s Gamaleya Institute has requested the Subject Expert Committee of the CDSCO to take into account its information for emergency use authorisation. The SEC is anticipated to take a name this week on granting approval to Russia’s Sputnik V, trials for which have been carried out by Dr Reddy’s Labs in India.

“We should take Pfizer up on their offer for domestic manufacture of their mRNA vaccine. High efficacy vaccines like Covovax and Pfizer’s mRNA vaccines may be required if immune escape variants of concern emerge. We should look at using such high efficacy vaccines in immunocompromised patients as there is evidence to suggest persistent infections in such patients can result in the emergence of immune escape variants,” Dr Parikh says.

“We can scale up vaccine manufacturing and vaccinate more people with at least 1 dose faster. In areas where variants of concern have been identified we should look at mass vaccinations as a ring immunization strategy,” he says.

On Monday, the Union Health Ministry did tweak the dosing routine strategy permitting Oxford University-produced Covishield to be administered 6-8 weeks aside citing enhancement of safety with the delay in administering the second dose.

“Unlock vaccination! The second Covid-19 wave mandates India to recalibrate and renegotiate its approach to this surge. A four-five fold increase in profession rate necessitates us to liberalize vaccine use,” says Dr Sanjeev Bagai, Chairman of Delhi’s Nephron Clinic.

This, consultants say will assist in breaking the chain of transmission and counter mutations.

At current, there are 400 sufferers within the nation who’ve been contaminated with the three mutant strains of the virus detected until now.

“We also need to help manufacturers scale production to meet rising demand. Procuring larger orders and helping them secure adequate raw materials would be a good idea. We should carefully examine if the price control is limiting their ability to scale and to compete for limited global raw material supplies,” says Professor Gautam Menon from Ashoka University.

At current, there are 40,000 vaccination websites within the nation. Prime Minister Modi in his assembly with chief ministers of states has requested them to work at growing vaccination websites.


Experts argue that vaccination has to goal the worst-affected districts in India.

As per information of the Union Health Ministry, 70 districts in India throughout 15 states have seen greater than a 150 per cent rise in new infections. 55 districts in 17 states have seen a rise in infections between 100 to 150 per cent.

The prime 10 districts reporting the utmost variety of new circumstances are Pune, Nagpur, Thane, Mumbai, Bengaluru Urban, Ernakulam, Amravati, Jalgaon, Nashik and Aurangabad. Punjab’s Ropar has seen a 256 per cent rise in circumstances and the spike in Maharashtra’s Nanded is 385 per cent.

“The steady increase in cases over the past few weeks across multiple states indicates that measures must be taken urgently to ensure that the health systems in those states are not overwhelmed. It is these states, and districts within them that are the most affected, that should see concerted and targeted interventions to reduce case numbers,” says Professor Menon.

“Take the vaccine to citizens and ensure a reformed strategic intervention,” says Dr Bagai.

“Hot zone areas are vulnerable; the vaccine must be accessible, affordable, administrable, accredited, and acceptable,” he provides.


These needs to be via the accelerated distribution of vaccination doses, elevated public sensitization in addition to rigorous enforcement of non-pharmaceutical interventions comparable to stopping crowds, requiring masking in addition to additional delaying the opening of academic establishments, say consultants.

“Public health programs can be scaled only if they are simple. Based on only age, the vaccination should be expanded without other restrictive criteria such as medical certification of comorbidities. Eventually, age groups should expand progressively towards younger ages in increments, starting from the current 60+ till 18 years. Eligible persons should get vaccinated at any designated place at a fixed price regulated by the government. The government needs to purchase the vaccines only for persons below the poverty line while those who can afford should be allowed to pay for their vaccination,” opines Professor Babu.

“Hot areas need to be identified and defined quickly,” says Dr Amrish Mittal. “Most of the pandemic has gone from the cities to interiors and if we have to take the vaccine to rural India, the messaging has to be very strong,” he says.


India has now crossed the determine of two million vaccinations per day. With an extra push, the goal of 300 million inoculations by July appear potential.

“Achieving 5 million vaccinations per day would appear to be feasible — we would really make a dent in the progress of the pandemic if we could do that,” says Professor Menon.

More than 4.72 crore doses of the vaccine have been administered ever because the drive started 65 days in the past in India. A complete of 4,72,07,134 vaccine doses have been given, as per the provisional report until 7 pm on Monday.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.